Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm

Shuyu Xie1,*, Baoliang Pan1,*, Baoxin Shi2, Zhuangzhi Zhang2, Xu Zhang2, Ming Wang1, Wenzhong Zhou11Department of Preventive Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing, People’s Republic of China; 2Veterinary Research Institute, Xinjiang...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xie S, Pan B, Shi B, Zhang Z, Zhang X, Wang M, Zhou W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/4cddc9f8ba7d4933aff60cc5f196607e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4cddc9f8ba7d4933aff60cc5f196607e
record_format dspace
spelling oai:doaj.org-article:4cddc9f8ba7d4933aff60cc5f196607e2021-12-02T02:10:26ZSolid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm1176-91141178-2013https://doaj.org/article/4cddc9f8ba7d4933aff60cc5f196607e2011-10-01T00:00:00Zhttp://www.dovepress.com/solid-lipid-nanoparticle-suspension-enhanced-the-therapeutic-efficacy--a8494https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Shuyu Xie1,*, Baoliang Pan1,*, Baoxin Shi2, Zhuangzhi Zhang2, Xu Zhang2, Ming Wang1, Wenzhong Zhou11Department of Preventive Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing, People’s Republic of China; 2Veterinary Research Institute, Xinjiang Academy of Animal Science, Xinjiang, People’s Republic of China *These authors contributed equally to this study Abstract: Hydatid disease caused by tapeworm is an increasing public health and socioeconomic concern. In order to enhance the therapeutic efficacy of praziquantel (PZQ) against tapeworm, PZQ-loaded hydrogenated castor oil solid lipid nanoparticle (PZQ-HCO-SLN) suspension was prepared by a hot homogenization and ultrasonication method. The stability of the suspension at 4°C and room temperature was evaluated by the physicochemical characteristics of the nanoparticles and in-vitro release pattern of the suspension. Pharmacokinetics was studied after subcutaneous administration of the suspension in dogs. The therapeutic effect of the novel formulation was evaluated in dogs naturally infected with Echinococcus granulosus. The results showed that the drug recovery of the suspension was 97.59% ± 7.56%. Nanoparticle diameter, polydispersivity index, and zeta potential were 263.00 ± 11.15 nm, 0.34 ± 0.06, and -11.57 ± 1.12 mV, respectively and showed no significant changes after 4 months of storage at both 4°C and room temperature. The stored suspensions displayed similar in-vitro release patterns as that of the newly prepared one. SLNs increased the bioavailability of PZQ 5.67-fold and extended the mean residence time of the drug from 56.71 to 280.38 hours. Single subcutaneous administration of PZQ-HCO-SLN suspension obtained enhanced therapeutic efficacy against tapeworm in infected dogs. At the dose of 5 mg/kg, the stool-ova reduction and negative conversion rates and tapeworm removal rate of the suspension were 100%, while the native PZQ were 91.55%, 87.5%, and 66.7%. When the dose reduced to 0.5 mg/kg, the native drug showed no effect, but the suspension still got the same therapeutic efficacy as that of the 5 mg/kg native PZQ. These results demonstrate that the PZQ-HCO-SLN suspension is a promising formulation to enhance the therapeutic efficacy of PZQ. Keywords: pharmacokinetics, hydatid disease, Echinococcus granulosusXie SPan BShi BZhang ZZhang XWang MZhou WDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2011, Iss default, Pp 2367-2374 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Xie S
Pan B
Shi B
Zhang Z
Zhang X
Wang M
Zhou W
Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
description Shuyu Xie1,*, Baoliang Pan1,*, Baoxin Shi2, Zhuangzhi Zhang2, Xu Zhang2, Ming Wang1, Wenzhong Zhou11Department of Preventive Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing, People’s Republic of China; 2Veterinary Research Institute, Xinjiang Academy of Animal Science, Xinjiang, People’s Republic of China *These authors contributed equally to this study Abstract: Hydatid disease caused by tapeworm is an increasing public health and socioeconomic concern. In order to enhance the therapeutic efficacy of praziquantel (PZQ) against tapeworm, PZQ-loaded hydrogenated castor oil solid lipid nanoparticle (PZQ-HCO-SLN) suspension was prepared by a hot homogenization and ultrasonication method. The stability of the suspension at 4°C and room temperature was evaluated by the physicochemical characteristics of the nanoparticles and in-vitro release pattern of the suspension. Pharmacokinetics was studied after subcutaneous administration of the suspension in dogs. The therapeutic effect of the novel formulation was evaluated in dogs naturally infected with Echinococcus granulosus. The results showed that the drug recovery of the suspension was 97.59% ± 7.56%. Nanoparticle diameter, polydispersivity index, and zeta potential were 263.00 ± 11.15 nm, 0.34 ± 0.06, and -11.57 ± 1.12 mV, respectively and showed no significant changes after 4 months of storage at both 4°C and room temperature. The stored suspensions displayed similar in-vitro release patterns as that of the newly prepared one. SLNs increased the bioavailability of PZQ 5.67-fold and extended the mean residence time of the drug from 56.71 to 280.38 hours. Single subcutaneous administration of PZQ-HCO-SLN suspension obtained enhanced therapeutic efficacy against tapeworm in infected dogs. At the dose of 5 mg/kg, the stool-ova reduction and negative conversion rates and tapeworm removal rate of the suspension were 100%, while the native PZQ were 91.55%, 87.5%, and 66.7%. When the dose reduced to 0.5 mg/kg, the native drug showed no effect, but the suspension still got the same therapeutic efficacy as that of the 5 mg/kg native PZQ. These results demonstrate that the PZQ-HCO-SLN suspension is a promising formulation to enhance the therapeutic efficacy of PZQ. Keywords: pharmacokinetics, hydatid disease, Echinococcus granulosus
format article
author Xie S
Pan B
Shi B
Zhang Z
Zhang X
Wang M
Zhou W
author_facet Xie S
Pan B
Shi B
Zhang Z
Zhang X
Wang M
Zhou W
author_sort Xie S
title Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
title_short Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
title_full Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
title_fullStr Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
title_full_unstemmed Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
title_sort solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/4cddc9f8ba7d4933aff60cc5f196607e
work_keys_str_mv AT xies solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT panb solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT shib solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT zhangz solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT zhangx solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT wangm solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
AT zhouw solidlipidnanoparticlesuspensionenhancedthetherapeuticefficacyofpraziquantelagainsttapeworm
_version_ 1718402647510220800